Pharma-Level Studies Of Kinetin Position Ingredient For Further Success

摘要

Studies on par with those generally reserved for prescription drugs could help distinguish Senetek' s Kinetin from other anti-aging agents on the market and support its broader use.Senetek's intellectual property related to kinetin - a cytokinin belonging to a class of growth hormones that delay senescence,or aging,in plants - is currently licensed and marketed by 14 companies.